Lipella Pharmaceuticals
LIPO
#10140
Rank
S$8.15 M
Marketcap
$3.20
Share price
1.24%
Change (1 day)
-58.93%
Change (1 year)

P/S ratio for Lipella Pharmaceuticals (LIPO)

P/S ratio as of April 2025 (TTM): 24.5

According to Lipella Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.24. At the end of 2024 the company had a P/S ratio of 15.0.

P/S ratio history for Lipella Pharmaceuticals from 2022 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202415.040.19%
202310.7-89.05%
202297.6